KN046 Clinical Trials
4 recruitingDrug
Phase 24Phase 11
Showing 1–4 of 4 trials
Recruiting
Phase 1Phase 2
IN10018+ Standard Chemotherapy (+KN046) in Subjects With Advanced Pancreatic Cancer
Pancreatic Cancer
InxMed (Shanghai) Co., Ltd.70 enrolled1 locationNCT05827796
Recruiting
Phase 2
Phase 2 Trial of KN026+KN046±XELOX in HER2-positive Locally Advanced GC
HER2-positive Locally Advanced Resectable Gastric Cancer
Peking University18 enrolled1 locationNCT06023758
Recruiting
Phase 2
KN 046 Plus Regorafenib in MSS Metastatic Colorectal Cancer
Peking University Cancer Hospital & Institute98 enrolled1 locationNCT05985109
Recruiting
Phase 2
KN046 Plus Regorafenib or Apatinib in MSI-H Digestive System Cancers Resistant to PD-1/PD-L1 Blockade
Digestive System Cancers
Peking University Cancer Hospital & Institute39 enrolled1 locationNCT06099821